Steward Partners Investment Advisory’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $5.65K | Sell |
|
|||||
|
2022
Q3 | $13K | Hold |
|
|||||
|
2022
Q2 | $8K | Hold |
|
|||||
|
2022
Q1 | $7K | Sell |
|
|||||
|
2021
Q4 | $19K | Sell |
|
|||||
|
2021
Q3 | $44K | Sell |
|
|||||
|
2021
Q2 | $68K | Sell |
|
|||||
|
2021
Q1 | $2.1M | Buy |
|
|||||
|
2020
Q4 | $948K | Sell |
|
|||||
|
2020
Q3 | $758K | Sell |
|
|||||
|
2020
Q2 | $780K | Buy |
|
|||||
|
2020
Q1 | $638K | Sell |
|
|||||
|
2019
Q4 | $713K | Buy |
|
|||||
|
2019
Q3 | $408K | Buy |
|
|||||
|
2019
Q2 | $793K | Buy |
|
|||||
|
2019
Q1 | $736K | Buy |
|
|||||
|
2018
Q4 | $736K | Buy |
|
|||||
|
2018
Q3 | $712K | Buy |
|
|||||
|
2018
Q2 | $728K | Buy |
|
|||||
|
2018
Q1 | $687K | Buy |
|
|||||
|
2017
Q4 | $404K | Buy |
|
|||||
|
2017
Q3 | $73K | Buy |
|
|||||
|
2017
Q2 | $34K | Hold |
|
|||||
|
2017
Q1 | $41K | Buy |
|